Latest

Bentham Science Publishers

·April 18, 2025·5 min read

Potential Depression Risk Linked to Ozempic-Like Drugs

A new international study reveals a possible connection between GLP1 receptor agonists—used in drugs like Ozempic—and increased risk of depression and suicidal ideation, especially in people with low dopamine function. Researchers used advanced pharmacogenomic tools to identify genetic pathways that may be vulnerable to dopamine dysregulation when exposed to these medications.

Featured Neurology Neuroscience

·April 9, 2024·6 min read

Cannabis Use Linked to Lower Dementia Risk

Recreational cannabis use may be associated with a significant decrease in the odds of experiencing subjective cognitive decline (SCD) in adults over 45. Analyzing data from the CDC's 2021 Behavioral Risk Factor Surveillance System, researchers found that recreational users had 96% lower odds of reporting SCD compared to non-users.

This shows two cute robots sitting on a laptop

Featured Neuroscience

·April 4, 2023·1 min read

Affective Computing: Computers Have Feelings Too

Researchers turn to affective computing, a branch of artificial intelligence that promotes emotional intelligence in algorithms, to recognize, process, interpret, and simulate human empathy.

Featured Neurology Neuroscience

·April 25, 2022·6 min read

Could Pulsed Electronically Generated Electromagnetic Fields Cause Alzheimer’s?

Pulsed electronically generated electromagnetic fields (EMFs) used for wireless communications produce electric and magnetic forces that act in the body's cells by activating voltage-gated calcium channels (VGCCs). VGCC activation induces changes that increase intracellular calcium levels. Researchers link EMF exposure to changes that lead to excessive intracellular calcium. This could have implications for the development of Alzheimer's disease.